| scholarly article | Q13442814 |
| P50 | author | Barbara Zawilinska | Q91924666 |
| Slawa Szostek | Q91924667 | ||
| Beata Piatkowska-Jakubas | Q125270080 | ||
| Aleksander Skotnicki | Q65159672 | ||
| P2093 | author name string | Jolanta Kopec | |
| Magdalena Kosz-Vnenchak | |||
| P2860 | cites work | Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey | Q71992794 |
| Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS | Q72815540 | ||
| Correlation between CMV genotypes, multiple infections with herpesviruses (HHV-6, 7) and development of CMV disease in kidney recipients in Kuwait | Q73104904 | ||
| Co-infection of two beta-herpesviruses (CMV and HHV-7) as an increased risk factor for 'CMV disease' in patients undergoing renal transplantation | Q73117697 | ||
| Association between human herpesvirus type 6 and type 7, and cytomegalovirus disease in heart transplant recipients | Q77958679 | ||
| The incidence and risk factors for chronic graft-versus-host-disease | Q80311320 | ||
| Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients | Q81633959 | ||
| Hematopoietic stem cell transplantation: a global perspective | Q24624697 | ||
| Definitions of cytomegalovirus infection and disease in transplant recipients | Q28210268 | ||
| Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles | Q34569079 | ||
| The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation | Q34768066 | ||
| Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation | Q36095851 | ||
| Human cytomegalovirus, endothelial function and atherosclerosis. | Q36279141 | ||
| Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing | Q37220021 | ||
| Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours | Q37228408 | ||
| Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology | Q37751339 | ||
| Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1. | Q37793819 | ||
| Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy | Q38317813 | ||
| Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia | Q40186252 | ||
| Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir | Q40671799 | ||
| The cytomegalovirus antigenemia assay: a plea for standardization. | Q41007938 | ||
| Hematopoietic stem cell transplantation for T315I-mutated chronic myelogenous leukemia. | Q42958613 | ||
| "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? | Q43604508 | ||
| In situ detection of DNA and mRNA of human cytomegalovirus to distinguish different forms of viral infection in leukocytes. | Q43694935 | ||
| The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease | Q43940394 | ||
| Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection | Q44412730 | ||
| Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load. | Q44479231 | ||
| A convenient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation | Q44526240 | ||
| Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients | Q44775294 | ||
| Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation | Q44956449 | ||
| An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes | Q46177065 | ||
| Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation. | Q52132971 | ||
| Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
| PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION | Q57181387 | ||
| Prevalence of HHV-6 integrated chromosomally among children treated for acute lymphoblastic or myeloid leukemia in the Czech Republic | Q59234124 | ||
| Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients | Q59699905 | ||
| Lymphotropic herpesviruses in allogeneic bone marrow transplantation | Q71735237 | ||
| P433 | issue | 8 | |
| P304 | page(s) | CR432-441 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation | |
| P478 | volume | 17 |
| Q90403930 | Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy |
| Q37501878 | Co-infections with cytomegalovirus and human herpesvirus type 7 in adult Polish allogeneic haematopoietic stem cell transplant recipients. |
| Q36577327 | Improved real-time PCR assay for detection and quantification of all 54 known types of human adenoviruses in clinical samples |
| Q89366245 | New Developments in the Management of Cytomegalovirus Infection After Transplantation |
| Q38256992 | Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials |
| Q46337798 | Using a Commonly Down-Regulated Cytomegalovirus (CMV) Promoter for High-Level Expression of Ectopic Gene in a Human B Lymphoma Cell Line. |
Search more.